chang recommend
downgrad fear loath
thesi updat follow fairli benign quarter
downgrad share outperform given heighten
medium term uncertainti think lack convict post
recent develop vs materi chang fundament view
lack convict ascertain quantifi potenti threat
lack thereof recent ftc investig recent experi
difficult disprov high level risk suggest share remain
rang bound disloc clariti gain possibl late
 earli earliest thu argu take fair
amount time investor gain comfort margin stabil long term
particularli coupl concern model slight
compress medium-term upsid particularli compel
move sidelin risk reward fairli balanc
frustrat develop frankli view super high
qualiti compani uniqu equiti also acknowledg
dynam time continu monitor situat bare
increment evid suggest margin stabil think
argument focus multipl expans vs ep upsid
challeng back increment color dental space
next week given chicago midwint well post
dental standout strength na equip
local currenc ex day impact dd growth tradit
equip high-tech modest recoveri consum result
out-performance
dental equip increas reflect highest
quarterli growth year
ftc alleg injunct relief seek monetari
damag fine clear timelin resolut matter
weak intern consum franchis continu
eu countri challeng itali weak franc
continu next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
chang
rais ep guidanc
tax rate rang
ep growth msd rang impact one-tim cash bonu
materi impact due adopt new revenu standard
believ alleg total meritless
complain seek injunct relief seek monetari damag
expect matter materi impact result
busi purchas organ continu
pace gm omx
restructur cost bp impact op margin year
acquisit complet ltm relat expens well certain sale switch agenc direct sale
exclud two adjust fy om approxim flat y-o-i
overal organ dental growth includ growth north america intern core ex day impact
consum growth equip sale local currenc ex day impact
henri schein stat million except per share data fy end septemb dental anim health medic organ gp growth revenu margin bp ebit growth gross profit ep share net incom price-to-earnings premium/discount isi healthcar technolog distribut februari
valuat price target base dcf methodolog contempl wacc termin
ebitda multipl equat perpetu growth rate pt translat ebitda vs
yr average
downsid risk potenti na consum trend remain subdu util anem impact
hdp crowd demand increas competit on-line channel notabl extend beyond basic consum
broader spectrum product price dental channel increasingli challeng dso competit heat defend
share ultim pressur om volatil fx rate depress medium-term profit trajectori complic effort
expand oper margin elev valuat broadli could slow derail manag strategi pursu consist tuck-
acquisit global competit dental equip market intensifi post key contract chang purchas
delay purchas high end
laboratori corp america hold
articl articl
time dissemin februari et
analyst ross muken elizabeth anderson suzi yoon primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view
